Copyright
©The Author(s) 2024.
World J Hepatol. Mar 27, 2024; 16(3): 439-451
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.439
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.439
Figure 1 Expression of sterol O-acyltransferase 1 and sterol O-acyltransferase 2 in The Cancer Genome Atlas-liver hepatocellular carcinoma.
A: Sterol O-acyltransferase 1 (SOAT1) and SOAT2 expression in the unpaired samples in The Cancer Genome Atlas (TCGA) liver hepatocellular carcinoma TCGA-LIHC; B: SOAT1 and SOAT2 expression in the paired samples in TCGA-LIHC; C: Forest diagram of univariate analysis of patients’ characteristics and SOAT1 expression; D: SOAT1 expression in the unpaired samples in TCGA pan-cancer; E: SOAT1 expression in the paired samples (E) in TCGA pan-cancer. aP < 0.05; bP < 0.01; cP < 0.001; NS: Not significant.
- Citation: Gan CJ, Zheng Y, Yang B, Cao LM. Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma. World J Hepatol 2024; 16(3): 439-451
- URL: https://www.wjgnet.com/1948-5182/full/v16/i3/439.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i3.439